News
Big psoriasis approval news and shocking speculation as AstraZeneca's CEO looks to jump to Teva - check out the week's ten most popular articles on...
McKinsey & Company discuss how pharma company executives need to seize every opportunity to embed productivity in their thinking and incorporate...
In a press conference at the White House, President Trump, alongside representatives from Corning, MSD and Pfizer, announced that 1,000 jobs would be...
GlaxoSmithKline will be scrapping plans for a new £350 million manufacturing plant in Ulverston, Cumbria, UK.
MSD, known as Merck in North America, has been granted approval for its biosimilar of Sanofi’s diabetes treatment, Lantus. Potentially, this could...
A blood test has been created that could offer an inexpensive, and less invasive, alternative to current Alzheimer’s disease tests. The method aims...
The European Commission has announced that it has decided to approve Leo Pharma’s Kyntheum (brodalumab), making it the first and only available...
Sanofi is steadily recovering from missing out on Actelion to J&J by making another deal, this time with Ablynx biotech to gain access to eight...
NICE has reached a decision in its final appraisal determination of Teva’s Cinqaero (reslizumab), recommending the drug’s use as an add-on...
